a b s t r a c t Diet-induced obesity and related peripheral and central inflammation are major risk factors for metabolic, neurological and psychiatric diseases. The chemokine fractalkine (Cx3CL1) and its receptor Cx3CR1 play a pivotal role in recruitment, infiltration and proinflammatory polarization of leukocytes and micoglial cells, however, the role of fractalkine signaling in the development of metabolic inflammation is not fully resolved. To address this issue, fractalkine receptor deficient (Cx3CR1 gfp/gfp) mice were exposed to normal or fat-enriched diet (FatED) for 10 weeks and physiological-, metabolic-and immune parameters were compared to those animals in which the fractalkine signaling is maintained by the presence of one functioning allele (Cx3CR1 +/gfp). Mice with intact fractalkine signaling develop obesity characterized by increased epididymal white fat depots and mild glucose intolerance, recruit leukocytes into the visceral adipose tissue and display increased expression of subset of pro-and anti-inflammatory cytokines when exposed to fat-enriched diet. By contrast, Cx3CR1-deficient (gfp/gfp) mice gain significantly less weight on fat-enriched diet and have smaller amount of white adipose tissue (WAT) in the visceral compartment than heterozygote controls. Furthermore, Cx3CR1 gfp/gfp mice fed a fat-enriched diet do not develop glucose intolerance, recruit proportionally less number of gfp-positive cells and express significantly less MCP-1, IL-1a and TNFa in the WAT than control animals with fat-enriched diet induced obesity. Furthermore, heterozygote obese, but not fractalkine receptor deficient mice express high levels of anti-inflammatory IL-10 and arginase1 markers in the visceral fat. The effect of fat-enriched diet on cytokine expression pattern was specific for the WAT, as we did not detect significant elevation of interleukin-1, tumor necrosis factor-alpha and monocyte chemotacting protein (MCP-1) expression in the liver or in the hypothalamus in either genotype. These results highlight the importance of fractalkine signaling in recruitment and polarization of adipose tissue immune cells and identify fractalkine as a target to fight obesity-induced inflammatory complications.
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Introduction
Energy metabolism is one of the most rigorously regulated homeostatic functions controlled by central and peripheral mechanisms (Schwartz et al., 2000) . During overload of fuels, excess of fat is deposited into the white adipose tissue (WAT) depots that are capable to synthesize and release various endocrine and immune mediators as well (Ahima and Flier, 2000; Ahima et al., 2000) . Visceral WAT from lean animals contains resident population of alternatively activated macrophages, which are characterized by expression of M2 markers such as arginase, F4/80 and CD301 (Weisberg et al., 2003) . Expanding WAT in obese subjects attracts various immune cells and release pro-inflammatory cytokines that contribute to the ''low grade chronic metabolic inflammation'' that represents a significant health burden (Tilg and Moschen, 2006) . Growing evidence implicates that obesity-inhttp://dx.doi.org/10.1016/j.bbi.2014.01.010 0889-1591/Ó 2014 Elsevier Inc. All rights reserved.
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